Encompass Health Corporat... (EHC)

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

EHC posts strong Q2 with higher EPS, revenue growth, and a raised 2025 outlook, along with shares gaining 7.4%.

Here is how Encompass Health (EHC) and Johnson & Johnson (JNJ) have performed compared to their sector so far this year.

While high dividend yields are enticing to many investors, the more relevant measurement of success of any stock is its total return. Total return includes a stock's dividend yield, as well as the cha...

Encompass Health Corporation (NYSE:EHC ) Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ET Company Participants Douglas E. Coltharp - Executive VP & CFO Mark Miller - Senior Vice President o...

Encompass Health (EHC) Q2 Revenue Up 12%

While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics co...

Encompass Health (EHC) came out with quarterly earnings of $1.4 per share, beating the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.11 per share a year ago.